Cosmos Health Inc (COSM)

$0.24 +0.02 (9.00%)
Market Cap 12.95M
Revenue (ttm) 65.27M
Net Income (ttm) -19.15M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 20.01
Profit Margin -29.34%
Debt to Equity Ratio 0.46
Volume 5,872,000
Avg Vol 11,628,670
Day's Range N/A - N/A
Shares Out 60.04M
Stochastic %K 89%
Beta 4.83
Analysts Strong Buy
Price Target $4.50

Company Profile

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It offers ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogre...

Industry: Medical Distribution
Sector: Healthcare
Phone: 312 536 3102
Address:
5 Agiou Georgiou Str, Pilea, Thessaloniki, Greece
Stopcryin
Stopcryin Aug. 4 at 2:18 PM
$COSM How beautiful 🤭😊🤭
0 · Reply
Stopcryin
Stopcryin Aug. 4 at 2:13 PM
$COSM Wait for the RS
0 · Reply
Stopcryin
Stopcryin Aug. 4 at 2:12 PM
$COSM Folks, he's not YOUR friend ... get that through your thick slulls! 🤣
0 · Reply
Stopcryin
Stopcryin Aug. 4 at 2:10 PM
$COSM I warned you about this CEO @Akis1965 and its stock! There's a reason why they call me Mr. Never Wrong! We Shorts will never lose with this cash cow! 😂🤑🤑🤑😂
0 · Reply
uddin
uddin Aug. 4 at 1:57 PM
$COSM $CDT Buying opportunity 🔥💯
0 · Reply
tommiemac
tommiemac Aug. 4 at 1:51 PM
$COSM looking for good entry
0 · Reply
Will3732
Will3732 Aug. 4 at 1:36 PM
$COSM bye bit the fun is just starting. Earnings soon.
1 · Reply
KJolive
KJolive Aug. 4 at 1:34 PM
$COSM I’m out 100k shares…. Was fun while it lasted
0 · Reply
Will3732
Will3732 Aug. 4 at 1:21 PM
$COSM lets get another 10% ish or more today!!!
0 · Reply
maximuswagimus
maximuswagimus Aug. 4 at 1:05 PM
$COSM Our time is coming.
0 · Reply
Latest News on COSM
Cosmos Health Advances Its Technology-Driven Transformation with an AI-Enabled Subscription Platform Across B2C and B2B Channels

Jul 27, 2026, 1:05 PM EDT - 7 days ago

Cosmos Health Advances Its Technology-Driven Transformation with an AI-Enabled Subscription Platform Across B2C and B2B Channels

Cosmos Health expands Sky Premium Life distribution pact with Pharma Cell

2026-07-20T19:50:15.000Z - 14 days ago

Cosmos Health expands Sky Premium Life distribution pact with Pharma Cell

Cosmos Health Expands Pharma Cell Partnership in Albania with Annualized Orders Projected to Exceed 54,000 Units

Jul 20, 2026, 3:46 PM EDT - 14 days ago

Cosmos Health Expands Pharma Cell Partnership in Albania with Annualized Orders Projected to Exceed 54,000 Units

Cosmos Health Share Buyback Expands to 5.11 Million Shares; Continues Open Market Repurchases

Jul 17, 2026, 2:55 PM EDT - 17 days ago

Cosmos Health Share Buyback Expands to 5.11 Million Shares; Continues Open Market Repurchases

Cosmos Health announces repurchase of additional 250,000 shares

2026-07-16T17:20:22.000Z - 18 days ago

Cosmos Health announces repurchase of additional 250,000 shares

Cosmos Health Share Buyback Surpasses $1 Million, Reaching 4.84 Million Shares; Continues Open Market Repurchases

Jul 16, 2026, 1:15 PM EDT - 18 days ago

Cosmos Health Share Buyback Surpasses $1 Million, Reaching 4.84 Million Shares; Continues Open Market Repurchases

Cosmos Health announces repurchase of additional 100,000 shares

2026-07-15T18:20:12.000Z - 19 days ago

Cosmos Health announces repurchase of additional 100,000 shares

Cosmos Health Share Buyback Surpasses 4.5 Million Shares; Continues Open Market Repurchases

Jul 15, 2026, 2:15 PM EDT - 19 days ago

Cosmos Health Share Buyback Surpasses 4.5 Million Shares; Continues Open Market Repurchases

Cosmos Health stock buyback expands to 4.49M shares

2026-07-14T18:45:10.000Z - 20 days ago

Cosmos Health stock buyback expands to 4.49M shares

Cosmos Health Share Buyback Expands to 4.49 Million Shares; Continues Open Market Repurchases

Jul 14, 2026, 2:40 PM EDT - 20 days ago

Cosmos Health Share Buyback Expands to 4.49 Million Shares; Continues Open Market Repurchases

Cosmos Health repurchases additional 215,000 common shares in open market

2026-07-13T19:05:14.000Z - 21 days ago

Cosmos Health repurchases additional 215,000 common shares in open market

Cosmos Health Share Buyback Reaches 4.36 Million Shares; Continues Open Market Repurchases

Jul 13, 2026, 3:00 PM EDT - 21 days ago

Cosmos Health Share Buyback Reaches 4.36 Million Shares; Continues Open Market Repurchases

Cosmos Health reports Libytec partnership to commercialize Diabit-IS X in Greece

2026-07-13T17:05:17.000Z - 21 days ago

Cosmos Health reports Libytec partnership to commercialize Diabit-IS X in Greece

Cosmos Health Accelerates Prescription Medicine Strategy with Libytec Partnership to Commercialize DIABIT-IS X in Greece

Jul 13, 2026, 1:00 PM EDT - 21 days ago

Cosmos Health Accelerates Prescription Medicine Strategy with Libytec Partnership to Commercialize DIABIT-IS X in Greece

Cosmos Health launches subscription model

2026-07-10T15:00:12.000Z - 24 days ago

Cosmos Health launches subscription model

Cosmos Health Launches Subscription Model

Jul 10, 2026, 10:55 AM EDT - 24 days ago

Cosmos Health Launches Subscription Model

Cosmos Health announces repurchase of additional 80,000 shares

2026-07-09T19:50:56.000Z - 25 days ago

Cosmos Health announces repurchase of additional 80,000 shares

Cosmos Health Expands Share Buyback to 4.14 Million Shares; Continues Open Market Repurchases

Jul 9, 2026, 3:45 PM EDT - 25 days ago

Cosmos Health Expands Share Buyback to 4.14 Million Shares; Continues Open Market Repurchases

Cosmos Health announces repurchase of additional 190,000 shares

2026-07-08T19:55:19.000Z - 26 days ago

Cosmos Health announces repurchase of additional 190,000 shares

Cosmos Health Share Buyback Surpasses 4 Million Shares; Continues Open Market Repurchases

Jul 8, 2026, 3:40 PM EDT - 26 days ago

Cosmos Health Share Buyback Surpasses 4 Million Shares; Continues Open Market Repurchases

Cosmos Health announces repurchase of additional 230,000 shares

2026-07-07T18:30:11.000Z - 27 days ago

Cosmos Health announces repurchase of additional 230,000 shares

Cosmos Health Share Buyback Expands to 3.87 Million Shares; Continues Open Market Repurchases

Jul 7, 2026, 2:27 PM EDT - 27 days ago

Cosmos Health Share Buyback Expands to 3.87 Million Shares; Continues Open Market Repurchases

Cosmos Health reports preliminary Q2 revenue $19.4M

2026-07-07T13:35:24.000Z - 4 weeks ago

Cosmos Health reports preliminary Q2 revenue $19.4M

Cosmos Health Reports Preliminary Record Q2 and H1 2026 Revenue, Up Over 30% Year-Over-Year; Continues Open Market Share Repurchases

Jul 7, 2026, 9:29 AM EDT - 4 weeks ago

Cosmos Health Reports Preliminary Record Q2 and H1 2026 Revenue, Up Over 30% Year-Over-Year; Continues Open Market Share Repurchases

Cosmos Health announces repurchase of additional 220,000 shares

2026-07-06T18:40:08.000Z - 4 weeks ago

Cosmos Health announces repurchase of additional 220,000 shares

Cosmos Health Share Buyback Increases to 3.64 Million Shares; Continues Open Market Purchases

Jul 6, 2026, 2:30 PM EDT - 4 weeks ago

Cosmos Health Share Buyback Increases to 3.64 Million Shares; Continues Open Market Purchases

Cosmos Health expands buyback with additional 770,000 share repurchase

2026-07-02T18:15:08.000Z - 4 weeks ago

Cosmos Health expands buyback with additional 770,000 share repurchase

Cosmos Health Expands Buyback to 3.42 Million Shares With Additional 770,000-Share Repurchase; Continues Open Market Purchases

Jul 2, 2026, 2:10 PM EDT - 4 weeks ago

Cosmos Health Expands Buyback to 3.42 Million Shares With Additional 770,000-Share Repurchase; Continues Open Market Purchases

Cosmos Health Completes Initial Repurchase of 2.65 Million Shares for $500,000; Continues Open Market Buybacks at Current Pace

Jul 1, 2026, 11:05 AM EDT - 4 weeks ago

Cosmos Health Completes Initial Repurchase of 2.65 Million Shares for $500,000; Continues Open Market Buybacks at Current Pace

Cosmos Health authorizes up to $5M share repurchase program

2026-06-30T16:00:32.000Z - 4 weeks ago

Cosmos Health authorizes up to $5M share repurchase program

Cosmos Health Authorizes Up to $5 Million Share Repurchase Program

Jun 30, 2026, 11:55 AM EDT - 4 weeks ago

Cosmos Health Authorizes Up to $5 Million Share Repurchase Program

Cosmos Health signs distribution agreement with IMC

2026-06-26T16:35:09.000Z - 5 weeks ago

Cosmos Health signs distribution agreement with IMC

Cosmos Health Signs Distribution Agreement With IMC, Owner of Qatar's Largest Pharmacy Chain; Secures Initial Purchase Order of 31,000 Sky Premium Life Units

Jun 26, 2026, 12:30 PM EDT - 5 weeks ago

Cosmos Health Signs Distribution Agreement With IMC, Owner of Qatar's Largest Pharmacy Chain; Secures Initial Purchase Order of 31,000 Sky Premium Life Units

Cosmos Health’s Cana advances international patent application

2026-06-25T19:40:17.000Z - 5 weeks ago

Cosmos Health’s Cana advances international patent application

Cosmos Health Advances International Patent Application for Its Proprietary Hydrogel Weight Management Platform Across the U.S., Europe, Australia, and Canada

Jun 25, 2026, 3:31 PM EDT - 5 weeks ago

Cosmos Health Advances International Patent Application for Its Proprietary Hydrogel Weight Management Platform Across the U.S., Europe, Australia, and Canada

Cosmos Health's C-Sept PRO Gains Strong Traction Across Leading Greek Public and Private Hospital Groups, With Annualized Sales Poised to Exceed $1.3 Million at Approximately 72% Gross Margin

Jun 24, 2026, 3:37 PM EDT - 5 weeks ago

Cosmos Health's C-Sept PRO Gains Strong Traction Across Leading Greek Public and Private Hospital Groups, With Annualized Sales Poised to Exceed $1.3 Million at Approximately 72% Gross Margin

Cosmos Health to deploy AI-powered call center

2026-06-23T19:40:11.000Z - 5 weeks ago

Cosmos Health to deploy AI-powered call center

Cosmos Health Signs Agreement to Deploy Artificial Intelligence (AI)-Powered Call Center to Optimize Order Intake, Customer Communications, and Operating Efficiency

Jun 23, 2026, 3:35 PM EDT - 5 weeks ago

Cosmos Health Signs Agreement to Deploy Artificial Intelligence (AI)-Powered Call Center to Optimize Order Intake, Customer Communications, and Operating Efficiency

Cosmos Health builds contract manufacturing orderbook to over 25M units

2026-06-22T14:40:08.000Z - 6 weeks ago

Cosmos Health builds contract manufacturing orderbook to over 25M units

Cosmos Health Builds Contract Manufacturing Orderbook to Over 25 Million Units; Division Positioned to Generate Over $10 Million in Recurring Annual Profit

Jun 22, 2026, 10:30 AM EDT - 6 weeks ago

Cosmos Health Builds Contract Manufacturing Orderbook to Over 25 Million Units; Division Positioned to Generate Over $10 Million in Recurring Annual Profit

CosmoFarm Delivers Record Q2 2026 Revenue of Over $15M, Representing $60+ Million Annualized Run-Rate; Adds Over 80 Pharmacies and Expands AI Automation and Facility Capacity

Jun 18, 2026, 3:34 PM EDT - 6 weeks ago

CosmoFarm Delivers Record Q2 2026 Revenue of Over $15M, Representing $60+ Million Annualized Run-Rate; Adds Over 80 Pharmacies and Expands AI Automation and Facility Capacity

Cosmos Health Enters the $163 Billion Global Skincare Market; Sales Already Underway in the United States

Jun 17, 2026, 3:35 PM EDT - 6 weeks ago

Cosmos Health Enters the $163 Billion Global Skincare Market; Sales Already Underway in the United States

Cosmos Health Signs 2.86 Million-Unit Contract Manufacturing Agreement With Pharmex S.A. Across Three Dermatological Products

Jun 17, 2026, 9:27 AM EDT - 6 weeks ago

Cosmos Health Signs 2.86 Million-Unit Contract Manufacturing Agreement With Pharmex S.A. Across Three Dermatological Products

Cosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit

Jun 15, 2026, 9:00 AM EDT - 7 weeks ago

Cosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit

Cosmos Health’s Cana wins contract manufacturing orders totaling 253,657 units

2026-06-12T19:40:29.000Z - 7 weeks ago

Cosmos Health’s Cana wins contract manufacturing orders totaling 253,657 units

Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines

Jun 12, 2026, 3:33 PM EDT - 7 weeks ago

Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines

Cosmos Health Reports Annualized Sales Exceeding $1.5M for Its C-Scrub and C-Sept Antiseptic Brands in the UK and Greece; Plans EU Expansion Targeting $7.4M in Revenue and $5.3M in Gross Profit

Jun 12, 2026, 9:29 AM EDT - 7 weeks ago

Cosmos Health Reports Annualized Sales Exceeding $1.5M for Its C-Scrub and C-Sept Antiseptic Brands in the UK and Greece; Plans EU Expansion Targeting $7.4M in Revenue and $5.3M in Gross Profit

Cosmos Health to acquire Doc Pharma, terms undisclosed

2026-06-11T19:35:09.000Z - 7 weeks ago

Cosmos Health to acquire Doc Pharma, terms undisclosed

Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio

Jun 11, 2026, 3:31 PM EDT - 7 weeks ago

Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio

Cosmos Health Signs 3-Year Contract Manufacturing Agreement with Verisfield for 3.9 Million Units of VASCLOR GEST Progesterone Pessaries

Jun 10, 2026, 3:32 PM EDT - 7 weeks ago

Cosmos Health Signs 3-Year Contract Manufacturing Agreement with Verisfield for 3.9 Million Units of VASCLOR GEST Progesterone Pessaries

Cosmos Health CEO Issues Letter to Shareholders: Building an Innovative AI-Driven Global Healthcare Platform — Record Growth with U.S. Expansion Underway

Jun 10, 2026, 9:00 AM EDT - 7 weeks ago

Cosmos Health CEO Issues Letter to Shareholders: Building an Innovative AI-Driven Global Healthcare Platform — Record Growth with U.S. Expansion Underway

Cosmos Health Inaugurates State-of-the-Art Capsule Production Line with New 5-Year Contract Manufacturing Agreement with Provident Pharmaceuticals for 385,000 Units of CERTORUN

Jun 9, 2026, 3:30 PM EDT - 7 weeks ago

Cosmos Health Inaugurates State-of-the-Art Capsule Production Line with New 5-Year Contract Manufacturing Agreement with Provident Pharmaceuticals for 385,000 Units of CERTORUN

Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives

Jun 8, 2026, 10:00 AM EDT - 2 months ago

Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives

Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories

Jun 5, 2026, 9:25 AM EDT - 2 months ago

Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories

Cosmos Health Achieves Pan-European Distribution for Sky Premium Life Across All 27 EU Member States Through Leading E-Commerce Platform Skroutz

Jun 4, 2026, 3:57 PM EDT - 2 months ago

Cosmos Health Achieves Pan-European Distribution for Sky Premium Life Across All 27 EU Member States Through Leading E-Commerce Platform Skroutz

Cosmos Health Identifies Approximately $20 Million in Non-Core Assets Available for Monetization to Accelerate Growth and Unlock Shareholder Value

Jun 4, 2026, 9:25 AM EDT - 2 months ago

Cosmos Health Identifies Approximately $20 Million in Non-Core Assets Available for Monetization to Accelerate Growth and Unlock Shareholder Value

Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657

Jun 1, 2026, 8:25 AM EDT - 2 months ago

Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657

Cosmos Health Releases 2026–2029 Guidance: Targeting $200M Revenue, $71M Gross Profit, and $44M Adjusted EBITDA by 2029 — Building an Innovative, High-Margin Healthcare Platform with Strong Cash Generation

May 26, 2026, 9:34 AM EDT - 2 months ago

Cosmos Health Releases 2026–2029 Guidance: Targeting $200M Revenue, $71M Gross Profit, and $44M Adjusted EBITDA by 2029 — Building an Innovative, High-Margin Healthcare Platform with Strong Cash Generation

Cosmos Health Announces Expiration of 4,874,126 Series B Warrants Unexercised; ~38% of Total Outstanding Warrants

May 21, 2026, 2:20 PM EDT - 2 months ago

Cosmos Health Announces Expiration of 4,874,126 Series B Warrants Unexercised; ~38% of Total Outstanding Warrants

Cosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues into Q2 with U.S. Expansion Underway

May 21, 2026, 9:15 AM EDT - 2 months ago

Cosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues into Q2 with U.S. Expansion Underway

Cosmos Health, through its Subsidiary Cana Laboratories, Enters into an Advisory Agreement with the European Investment Bank (EIB) for the Financing of its €50M R&D Program; EIB Financing Represents up to 50%, or €25M, under the EIB's Venture Debt Program

May 14, 2026, 9:00 AM EDT - 2 months ago

Cosmos Health, through its Subsidiary Cana Laboratories, Enters into an Advisory Agreement with the European Investment Bank (EIB) for the Financing of its €50M R&D Program; EIB Financing Represents up to 50%, or €25M, under the EIB's Venture Debt Program

Cosmos Health Announces Withdrawal of Registration Statement on Form S-1

May 12, 2026, 10:15 AM EDT - 3 months ago

Cosmos Health Announces Withdrawal of Registration Statement on Form S-1

Cosmos Health Projects Over $3.2 Million in Incremental Annual Revenue from Fort18 in the United States Within 12-18 Months

May 11, 2026, 2:25 PM EDT - 3 months ago

Cosmos Health Projects Over $3.2 Million in Incremental Annual Revenue from Fort18 in the United States Within 12-18 Months

Cosmos Health Receives Updated Zacks Research Report: 2026 Revenue Forecast Raised to $103.2 Million, EPS Outlook Upgraded to Positive Territory, and $4.50 Valuation Reaffirmed

May 8, 2026, 11:25 AM EDT - 3 months ago

Cosmos Health Receives Updated Zacks Research Report: 2026 Revenue Forecast Raised to $103.2 Million, EPS Outlook Upgraded to Positive Territory, and $4.50 Valuation Reaffirmed

Cosmos Health Projects Over $2.5 Million in Incremental Annual Revenue from Cur18 in the United States Within 12-18 Months

Apr 30, 2026, 12:50 PM EDT - 3 months ago

Cosmos Health Projects Over $2.5 Million in Incremental Annual Revenue from Cur18 in the United States Within 12-18 Months

Cosmos Health Introduces the "18 Series" in the United States - A Science-Driven Nutraceutical Platform Built on Patented Ingredients, Published Clinical Research, and Exact Clinical Dosing; Targeting a Portfolio of 18 Clinically Validated Products

Apr 21, 2026, 12:50 PM EDT - 3 months ago

Cosmos Health Introduces the "18 Series" in the United States - A Science-Driven Nutraceutical Platform Built on Patented Ingredients, Published Clinical Research, and Exact Clinical Dosing; Targeting a Portfolio of 18 Clinically Validated Products

Cosmos Health Accelerates U.S. Expansion: Liv18 Phase 1 Execution Complete; Production and Sales Commencing April 2026; Expected to Generate $5M+ in Annual Revenue at ~75% Gross Margins; Early U.S. Commercial Traction Observed Across Product Portfolio

Apr 20, 2026, 10:55 AM EDT - 3 months ago

Cosmos Health Accelerates U.S. Expansion: Liv18 Phase 1 Execution Complete; Production and Sales Commencing April 2026; Expected to Generate $5M+ in Annual Revenue at ~75% Gross Margins; Early U.S. Commercial Traction Observed Across Product Portfolio

Cosmos Health Continues US Expansion with Q2 Launch of Cur18 - a Clinically Studied, Patented Curcumin Next-Gen Therapy Supplement Delivering 39× Higher Bioavailability and Designed to Support Joint Health

Apr 17, 2026, 2:00 PM EDT - 3 months ago

Cosmos Health Continues US Expansion with Q2 Launch of Cur18 - a Clinically Studied, Patented Curcumin Next-Gen Therapy Supplement Delivering 39× Higher Bioavailability and Designed to Support Joint Health

Cosmos Health Advances AI Investments to Enhance Efficiency, Reduce Costs, Improve Customer Experience and Drive Sales Growth; Certain Operating Expenses May Decrease by Up to 30%

Apr 16, 2026, 3:15 PM EDT - 3 months ago

Cosmos Health Advances AI Investments to Enhance Efficiency, Reduce Costs, Improve Customer Experience and Drive Sales Growth; Certain Operating Expenses May Decrease by Up to 30%

Cosmos Health Reports Full Year 2025 Results: Revenue Hits All-Time Record of $65.3M, Up 20%; Gross Profit Surges 83% to $7.9M; Gross Margin Expands 418 Basis Points; Adjusted EPS Improves 82%; Cash Position Up 10x to $3.5M; Record Growth Continues Into 2026 Across All Core Segments

Apr 15, 2026, 9:25 AM EDT - 3 months ago

Cosmos Health Reports Full Year 2025 Results: Revenue Hits All-Time Record of $65.3M, Up 20%; Gross Profit Surges 83% to $7.9M; Gross Margin Expands 418 Basis Points; Adjusted EPS Improves 82%; Cash Position Up 10x to $3.5M; Record Growth Continues Into 2026 Across All Core Segments

Stopcryin
Stopcryin Aug. 4 at 2:18 PM
$COSM How beautiful 🤭😊🤭
0 · Reply
Stopcryin
Stopcryin Aug. 4 at 2:13 PM
$COSM Wait for the RS
0 · Reply
Stopcryin
Stopcryin Aug. 4 at 2:12 PM
$COSM Folks, he's not YOUR friend ... get that through your thick slulls! 🤣
0 · Reply
Stopcryin
Stopcryin Aug. 4 at 2:10 PM
$COSM I warned you about this CEO @Akis1965 and its stock! There's a reason why they call me Mr. Never Wrong! We Shorts will never lose with this cash cow! 😂🤑🤑🤑😂
0 · Reply
uddin
uddin Aug. 4 at 1:57 PM
$COSM $CDT Buying opportunity 🔥💯
0 · Reply
tommiemac
tommiemac Aug. 4 at 1:51 PM
$COSM looking for good entry
0 · Reply
Will3732
Will3732 Aug. 4 at 1:36 PM
$COSM bye bit the fun is just starting. Earnings soon.
1 · Reply
KJolive
KJolive Aug. 4 at 1:34 PM
$COSM I’m out 100k shares…. Was fun while it lasted
0 · Reply
Will3732
Will3732 Aug. 4 at 1:21 PM
$COSM lets get another 10% ish or more today!!!
0 · Reply
maximuswagimus
maximuswagimus Aug. 4 at 1:05 PM
$COSM Our time is coming.
0 · Reply
Mooseman236
Mooseman236 Aug. 4 at 12:53 PM
$COSM .
0 · Reply
Stopcryin
Stopcryin Aug. 4 at 11:55 AM
$COSM Breaking ... This just in !! Already Down 5% I knew we Shorts could count on our friend CEO Siokas @Akis1965 to bring this garbage back down for us. Thanks once again for your help! You always come through!
4 · Reply
Stopcryin
Stopcryin Aug. 4 at 11:49 AM
$COSM ... yea because what the CEO has done the last "long term" 5 years was a complete sheet-show. Give him another 5 years and relly see what this crook can do 😂🤣😂
1 · Reply
Skoufa
Skoufa Aug. 4 at 11:16 AM
$COSM CEO decided to increase his position , leaving cash in the company to grow faster and also improve the balance sheet. This is the mindset of a long term owner!!
0 · Reply
Skoufa
Skoufa Aug. 4 at 11:15 AM
$COSM coil spring 📈
0 · Reply
Skoufa
Skoufa Aug. 4 at 11:14 AM
$COSM quiet period before earnings. Program is still active and ongoing.
1 · Reply
PutridCoast
PutridCoast Aug. 4 at 6:22 AM
$COSM did they stop the buyback for now ?
0 · Reply
Favoredson
Favoredson Aug. 3 at 11:29 PM
$COSM Getting tighter everyday. Coiling.
0 · Reply
HeyHoser
HeyHoser Aug. 3 at 9:41 PM
$COSM Sad they allow this to continue. Toxic!
2 · Reply
HeyHoser
HeyHoser Aug. 3 at 9:40 PM
$COSM CEO didn't buy anything, read the footnote. https://www.sec.gov/Archives/edgar/data/1660125/000147793226004631/xslF345X06/form4.xml "1. Pursuant to a debt exchange agreement by and between Grigorios Siokas, the Company's CEO and the Company (the "Debt Exchange Agreement"), dated as of July 30, 2026, these shares are Exchange Shares (as defined in the Debt Exchange Agreement) being acquired by Mr. Siokas at the Exchange Rate (as defined in the Debt Exchange Agreement) of $0.2001 per share, the fair market value of the Common Stock on July 30, 2026, in exchange for a total amount of $70,000 in debt the Company owed to Mr. Siokas."
1 · Reply
Nobodycares777
Nobodycares777 Aug. 3 at 9:29 PM
$COSM someone w some MASSIVE shares is just flipping this thing for fun 🤣🤣🤣🤣🚀🚀🚀 STOP IT YOU DPSHIT
0 · Reply
Dragonslayer2065
Dragonslayer2065 Aug. 3 at 9:17 PM
$COSM Don't know if I want in right now, so what I'll do is limit buy at .15, which is trendline support, hoping it quickly scoops up my shares. This had to get over .30 to move.
0 · Reply